According to FDA labeling, these medications are indicated for improving glycemic control in adults with type 2 diabetes and, in higher doses for certain formulations, for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Meanwhile, the peptide mice exhibited a decrease in the number of tumor cells
1 Even though this slowdown in gut motility is by design, it also may be the reason many people on GLP-1 medications experience some initial digestive disturbances and discomfort
Restaurant-quality food delivered to your doorperfect portions, perfect macros, zero stress
In SURPASS-2, tirzepatide caused diarrhea in 13-16% of participants, while semaglutide 1 mg caused it in 12%